Seeking to improve yields and simplify the processes of vaccine production, a research team from WPI’s Biomanufacturing Education & Training Center (BETC) will present new data from their recent study of Vero cell growth in a semi-continuous bioprocess.
BETC Director and Research Professor, Kamal Rashid, PhD, will present the results in a talk titled “A packed-bed bioreactor system for enhancing the growth of Vero cells in a semi-continuous mode of operation” at the Society for Industrial Microbiology and Biotechnology (SIMB) 2016 Annual Meeting July 26 in New Orleans.
“Improving vaccine production can have a significant positive impact on global public health,” Rashid said. “So we are looking forward to seeing our colleagues in New Orleans and discussing ways to build upon this encouraging early data.”
An associated poster titled, “A packed-bed bioreactor systems for growth of anchorage dependent cells: A comparative study between Eppendorf’s BioBLU® 5p Single Use Vessel and the Traditional Glass Vessel” will be presented at the poster sessions July 24-25 by Shannon Guertin, who worked on the Vero cell project for her senior capstone project at WPI. (Upon graduation from WPI in May of 2016, Guertin accepted a position at AbbVie.)
This research was co-sponsored by Eppendorf and WPI’s Division of Academic and Corporate Engagement.
Written by Mike Cohen